跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
HMG-CoA reductase inhibitors (cancer)
首页
药物
HMG-CoA reductase inhibitors (cancer)
HMG-CoA reductase inhibitors (cancer)
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。
3,5,n-trihydroxy-alkanamide and derivatives: method for making same and use thereof
CN 104854082 A
申请人: ACADEMIA SINICA
优先权: 2013
CN
US
3 件公开
Farnesyl transferase inhibitors in combination with HMG CoA reductase inhibitors for the treatment of cancer
US 2005203163 A1
申请人: PFIZER
优先权: 2002
US
2 件公开
Composition and method for treating cancer
US 7074825 B2
申请人: MO HUANBIAO
优先权: 2003
US
2 件公开
Dual action inhibitors against histone deacetylases and 3-hydroxy-3-methylglutaryl coenzyme a reductase
US 9115116 B2
申请人: ACADEMIA SINICA
优先权: 2014
US
2 件公开
Combinations of protein farnesyltransferase and HMG CoA reductase inhibitors and their use to treat cancer
US 6492410 B1
申请人: WARNER LAMBERT CO
优先权: 2000
US
Compound of heterocyclic pyridine class
CN 1872859 A
申请人: WANG SONGFA
优先权: 2005
CN
Therapeutic compositions comprising chorionic gonadotropins and HMG CoA reductase inhibitors
US 2008139457 A1
申请人: UNIV VIRGINIA COMMONWEALTH
优先权: 2006
US
Methods for Treating Cancer
US 2007219208 A1
申请人: KALYANARAMAN BALARAMAN
优先权: 2007
US
药物
反馈
